Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-03-09 @ 12:53 AM
Study NCT ID:
NCT02241720
Status:
TERMINATED
Last Update Posted:
2018-01-11
First Post:
2013-11-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers
Sponsor:
University of Utah
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HCI68135
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None